Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global α-blocker Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Non-selective Antagonists
  • 1.3.3 Selective Antagonists
• 1.4 Market Segment by Application
  • 1.4.1 Global α-blocker Market Share by Application (2019-2025)
  • 1.4.2 Hypertension
  • 1.4.3 Raynaud's Disease
  • 1.4.4 Erectile Dysfunction
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global α-blocker Market Size
  • 2.1.1 Global α-blocker Revenue 2014-2025
  • 2.1.2 Global α-blocker Sales 2014-2025
• 2.2 α-blocker Growth Rate by Regions
  • 2.2.1 Global α-blocker Sales by Regions 2014-2019
  • 2.2.2 Global α-blocker Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 α-blocker Sales by Manufacturers
  • 3.1.1 α-blocker Sales by Manufacturers 2014-2019
  • 3.1.2 α-blocker Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 α-blocker Revenue by Manufacturers (2014-2019)
  • 3.2.2 α-blocker Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global α-blocker Market Concentration Ratio (CR5 and HHI)
• 3.3 α-blocker Price by Manufacturers
• 3.4 Key Manufacturers α-blocker Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into α-blocker Market
• 3.6 Key Manufacturers α-blocker Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Non-selective Antagonists Sales and Revenue (2014-2019)
  • 4.1.2 Selective Antagonists Sales and Revenue (2014-2019)
• 4.2 Global α-blocker Sales Market Share by Type
• 4.3 Global α-blocker Revenue Market Share by Type
• 4.4 α-blocker Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global α-blocker Sales by Application

6 United States

• 6.1 United States α-blocker Breakdown Data by Company
• 6.2 United States α-blocker Breakdown Data by Type
• 6.3 United States α-blocker Breakdown Data by Application

7 European Union

• 7.1 European Union α-blocker Breakdown Data by Company
• 7.2 European Union α-blocker Breakdown Data by Type
• 7.3 European Union α-blocker Breakdown Data by Application

8 China

• 8.1 China α-blocker Breakdown Data by Company
• 8.2 China α-blocker Breakdown Data by Type
• 8.3 China α-blocker Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World α-blocker Breakdown Data by Company
• 9.2 Rest of World α-blocker Breakdown Data by Type
• 9.3 Rest of World α-blocker Breakdown Data by Application
• 9.4 Rest of World α-blocker Breakdown Data by Countries
  • 9.4.1 Rest of World α-blocker Sales by Countries
  • 9.4.2 Rest of World α-blocker Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer
  • 10.1.1 Pfizer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of α-blocker
  • 10.1.4 α-blocker Product Introduction
  • 10.1.5 Pfizer Recent Development
• 10.2 Novartis
  • 10.2.1 Novartis Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of α-blocker
  • 10.2.4 α-blocker Product Introduction
  • 10.2.5 Novartis Recent Development
• 10.3 Merck
  • 10.3.1 Merck Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of α-blocker
  • 10.3.4 α-blocker Product Introduction
  • 10.3.5 Merck Recent Development
• 10.4 Astra Zeneca
  • 10.4.1 Astra Zeneca Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of α-blocker
  • 10.4.4 α-blocker Product Introduction
  • 10.4.5 Astra Zeneca Recent Development
• 10.5 Jhonson and Johnson
  • 10.5.1 Jhonson and Johnson Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of α-blocker
  • 10.5.4 α-blocker Product Introduction
  • 10.5.5 Jhonson and Johnson Recent Development
• 10.6 Eli Lilly
  • 10.6.1 Eli Lilly Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of α-blocker
  • 10.6.4 α-blocker Product Introduction
  • 10.6.5 Eli Lilly Recent Development
• 10.7 Sanofi
  • 10.7.1 Sanofi Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of α-blocker
  • 10.7.4 α-blocker Product Introduction
  • 10.7.5 Sanofi Recent Development
• 10.8 Bristol-Myers Squibb
  • 10.8.1 Bristol-Myers Squibb Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of α-blocker
  • 10.8.4 α-blocker Product Introduction
  • 10.8.5 Bristol-Myers Squibb Recent Development
• 10.9 Bayer
  • 10.9.1 Bayer Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of α-blocker
  • 10.9.4 α-blocker Product Introduction
  • 10.9.5 Bayer Recent Development
• 10.10 GSK
  • 10.10.1 GSK Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of α-blocker
  • 10.10.4 α-blocker Product Introduction
  • 10.10.5 GSK Recent Development
• 10.11 Teva Pharmaceutical

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 α-blocker Sales Channels
  • 11.2.2 α-blocker Distributors
• 11.3 α-blocker Customers

12 Market Forecast

• 12.1 Global α-blocker Sales and Revenue Forecast 2019-2025
• 12.2 Global α-blocker Sales Forecast by Type
• 12.3 Global α-blocker Sales Forecast by Application
• 12.4 α-blocker Forecast by Regions
  • 12.4.1 Global α-blocker Sales Forecast by Regions 2019-2025
  • 12.4.2 Global α-blocker Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
In 2019, the market size of α-blocker is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for α-blocker.

This report studies the global market size of α-blocker, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the α-blocker sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Market Segment by Product Type
Non-selective Antagonists
Selective Antagonists

Market Segment by Application
Hypertension
Raynaud's Disease
Erectile Dysfunction

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the α-blocker status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key α-blocker manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of α-blocker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025